Lebenthal Global Advisors’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,240
Closed -$291K 202
2025
Q2
$291K Sell
2,240
-375
-14% -$54.4K 0.05% 164
2025
Q1
$417K Hold
2,615
0.08% 148
2024
Q4
$485K Sell
2,615
-100
-4% -$19.4K 0.09% 136
2024
Q3
$573K Sell
2,715
-150
-5% -$26.1K 0.12% 114
2024
Q2
$383K Hold
2,865
0.08% 139
2024
Q1
$615K Sell
2,865
-175
-6% -$34.3K 0.14% 95
2023
Q4
$618K Sell
3,040
-15
-0.5% -$2.43K 0.14% 91
2023
Q3
$606K Sell
3,055
-25
-0.8% -$6.3K 0.18% 68
2023
Q2
$1,000K Sell
3,080
-160
-5% -$45.7K 0.29% 34
2023
Q1
$758K Sell
3,240
-59
-2% -$14.9K 0.23% 38
2022
Q4
$831K Sell
3,299
-41
-1% -$8.74K 0.27% 33
2022
Q3
$592K Hold
3,340
0.27% 42
2022
Q2
$610K Sell
3,340
-100
-3% -$19.9K 0.3% 52
2022
Q1
$883K Hold
3,440
0.38% 34
2021
Q4
$791K Sell
3,440
-100
-3% -$24.4K 0.32% 40
2021
Q3
$824K Buy
3,540
+400
+13% +$83.5K 0.52% 29
2021
Q2
$606K Buy
3,140
+800
+34% +$159K 0.33% 49
2021
Q1
$484K Buy
2,340
+185
+9% +$39.3K 0.3% 53
2020
Q4
$405K Buy
+2,155
New +$352K 0.29% 44

Other funds holding INSP

Lebenthal Global Advisors's INSP Position: Q3 2025 in Review

Lebenthal Global Advisors sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 2,240 shares — an estimated $291K sold.

Lebenthal Global Advisors first reported a position in INSP in Q4 2020 and held it in 19 quarters. The position peaked at $1,000K in Q2 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Lebenthal Global Advisors reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Lebenthal Global Advisors sold 2,240 Inspire Medical Systems shares in Q3 2025, an estimated $291K.
  • Lebenthal Global Advisors first reported a position in Inspire Medical Systems in Q4 2020 and held it in 19 quarters.
  • Lebenthal Global Advisors's Inspire Medical Systems position peaked at $1,000K in Q2 2023.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Lebenthal Global Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.